{
  "N/R/U": null,
  "Applicant": "Parke-Davis, a Division of Pfizer Inc.",
  "BLA Number": "50294",
  "Proprietary Name": "Elase-chloromycetin",
  "Proper Name": "fibrinolysin and desoxyribonuclease combined [bovine], with chloramphenicol",
  "BLA Type": "351(a)",
  "Strength": "10MG/GM; 666UNITS/GM; 1UNIT/GM",
  "Dosage Form": "Ointment",
  "Route of Administration": "Topical",
  "Product Presentation": "Tube",
  "Marketing Status": "Disc",
  "Licensure": "Voluntarily Revoked",
  "Approval Date": "1-Apr-64",
  "Ref. Product Proper Name": null,
  "Ref. Product Proprietary Name": null,
  "Supplement Number": null,
  "Submission Type": "Original",
  "License Number": "2205",
  "Product Number": "1",
  "Center": "CDER",
  "Date of First Licensure": null,
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": null,
  "Orphan Exclusivity Exp. Date": null
}